fda stopping compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA ends semaglutide shortage, closing

Possible Side Effects of L-Carnitine L-carnitine is generally safe, but some people may have mild side effects, mainly if they take too much or do not ask a doctor first

Schizophrenia risk from complex variation of complement component 4

A.CohenK.et al (2022)

Why is Rybelsus being phased out

Semaglutide and other GLP-1 medications are typically considered for individuals who: Have struggled to lose weight through diet and exercise alone Are committed to making sustainable lifestyle changes Are seeking to improve metabolic health under medical guidance Are overweight and have weight-related health conditions Have obesity Have a body mass index (BMI) of 30 or higher GLP-1 Weight Loss: What to Expect As with any medication, the effect of GLP-1 medication varies from patient to patient

Clinical trials demonstrate significant weight loss when combined with a reduced-calorie diet and increased physical activity